OGT releases an RNA-based NGS panel for AML, enabling detection of leukemia-associated gene fusions at 1% tumor cell levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results